| abstract |
The present invention relates to compounds that inhibit CD95 signaling in pancreatic cancer cells. Furthermore, the present invention contemplates pharmaceuticals comprising such compounds for preventing and / or treating pancreatic cancer, and preventing and / or treating pancreatic cancer, preventing cancer cell migration, and / or inflammatory response Use of such compounds for the manufacture of a medicament for the prevention and / or treatment of The present invention also relates to a method for identifying a CD95 signaling inhibitory compound, and a method for producing a pharmaceutical comprising the steps of a method for identifying a CD95 signaling inhibitory compound and the further step of formulating said inhibitory compound as a pharmaceutical. [Selection figure] None |